Back to list

Tennr

AI that reads referrals, faxes, and documents to automate healthcare front-office work.
Tennr builds AI (its 'RaeLLM') that reads and parses inbound referrals, faxes, and documents to automate front-office healthcare workflows, processing roughly 10M documents per month. Founded in 2021 by Trey Holterman, Diego Baugh, and Tyler Johnson, it raised a $101M Series C in 2025 led by IVP at a $605M valuation, for about $159M total.
HealthTech 📍 New York, USA Founded 2021
Current Valuation
$605M
as of 2025-Q3
PRIVATE

QL Price

$539.7M
-11% vs last round
QuantLogix's current estimate for Tennr, published 2026-09-21 — below the last disclosed round of $605M (2025-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round $605M 2025-Q3 weight 0.51
Secondary market print $484M 2026-06-27 weight 0.6
How this price has held up
No round has priced for Tennr since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-21 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Tennr →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Tennr, 2026-09-21 (1b74d63ed710918b). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Tennr going public?
No. Tennr is private and has not filed to go public. There is no S-1 on file.
What is Tennr's valuation in 2026?
Tennr is valued at $605M as of 2025-Q3, set by its Series C ($101M, Jul 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Tennr filed an S-1?
No public S-1 is on file for Tennr.
Who are Tennr's investors?
Tennr's investors include IVP, Andreessen Horowitz, Lightspeed Venture Partners, GV, ICONIQ, Foundation Capital.
Can you buy Tennr stock?
No. Tennr is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Tennr on its Pre-IPO Access Desk.
How to actually get exposure to Tennr →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
Trey Holterman
Founded
2021
HQ
New York, USA
Total Raised
$159M
Last Round
Series C — $101M (Jul 2025) · Lead: IVP
IPO Status
private

Fundraising Status

Series C · $101M · 1y 2mo ago
privateTotal raised $159M1 disclosed rounds

Series C Impact

Round Size
$101M
Primary financing announced
Post-Money Valuation
$605M
Company-announced mark
Round / Post-Money
16.7%
New capital ÷ post-money
Disclosed Funding
$159M
Cumulative disclosed rounds
Step-up compares disclosed post-money valuations. Round / post-money is a financing-size ratio, not an ownership or dilution estimate.

Secondary Market

Implied price / share
$23.5
Last round price / share
$29.39
vs last round
-20.0%
Open interest
1
Last round price vs secondary price
Last round vs current secondary price per share$29.39Last round$23.50Current
Secondary price return by period
Secondary market period returns3-month0.0%6-month0.0%1-year0.0%All-time0.0%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Funding History

RoundAmountDateLead InvestorPost-Money
Series C$101MJul 2025IVP$605M

Talent Signal

Hiring trend
Hiring uptrend
+25% vs 2026-08
Open roles
25
via ashby
Product-build share
36%
engineering, research, product, design
Trajectory
expanding
balanced build + GTM — 36% builders vs 64% go-to-market/G&A — scaling both sides.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by month20Aug '2625Sep '26
Open roles by function
Open roles by functionEngineering7Other7Sales & GTM5Ops & People3Clinical & Science1Marketing1Design1
product-building   go-to-market / G&A
Clinical Criteria Escalations SpecialistBackend Software EngineerProduct EngineerSenior Product EngineerSenior UX EngineerSenior Forward Deployed Engineer
Counted from Tennr's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Trey HoltermanDiego BaughTyler Johnson

Investors

IVP · Andreessen Horowitz · Lightspeed Venture Partners · GV · ICONIQ · Foundation Capital

Products

  • RaeLLM document automation for healthcare

Competitors

Notable Health · Infinitus · Adonis
healthtechaiworkflow automationhealthcaredocument processing
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q3. Refreshed quarterly.